Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Mega Cap Growth ETF (MGK) vs Altria Group Inc (MO) Price & Performance

Vanguard Mega Cap Growth ETFTrade
Altria Group IncTrade

Price performance (Past 24H)

Key statistics

Vanguard Mega Cap Growth ETF vs Altria Group Inc — how do they compare? Vanguard Mega Cap Growth ETF trades at $90.02, while Altria Group Inc trades at $65.03 (market cap $114.13B). The key difference: Altria Group Inc pays a 6.2% dividend while Vanguard Mega Cap Growth ETF pays none, and Vanguard Mega Cap Growth ETF is trading nearer its 52-week high, Altria Group Inc nearer its low. Which is the better fit depends on your goals.

MGKMO
Sector
Broad Market / FactorConsumer Staples
52-Week High
$92.06$74.92
52-Week Low
$70.70$54.72
Market Cap
$114.13B
Enterprise Value
$136.34B
Dividend Yield
6.2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard Mega Cap Growth ETF

MGK, the Vanguard Mega Cap Growth ETF, trades at $90.79, up 0.87% on the day, with a bullish technical signal driven by strong moving average alignment. The ETF's concentrated portfolio of 69 large-cap U.S. growth stocks, heavily weighted toward technology and consumer discretionary sectors, has delivered robust historical returns. Recent news highlights its low 0.05% expense ratio and potential inclusion of high-profile stocks like SpaceX, reinforcing its appeal for growth-oriented investors seeking mega-cap exposure.

The outlook for MGK remains positive due to its focus on leading growth companies, but risks include high concentration in tech stocks and sensitivity to market volatility. Investors benefit from cost efficiency and historical outperformance, yet must monitor sector-specific downturns and valuation pressures. The ETF is suited for long-term growth strategies with tolerance for drawdowns.

Altria Group Inc

Altria Group (MO) trades at $68.35, up 0.89% with mixed technical signals showing bearish moving averages but oversold RSI levels. The company maintains strong profitability with 39% net income margin and $6.95B net income for 2025, though revenue declined slightly to $20.14B. Recent earnings show alternating beats and misses, with Q3 2026 results pending. Analyst consensus remains bullish with 61.5% buy ratings and $71.50 price target, while the stock offers a 6.3% dividend yield with 56 consecutive annual increases expected.

MO presents value opportunity with 14.4x P/E ratio and strong cash flow generation, but faces headwinds from cigarette volume declines and regulatory pressures. The smoke-free product transition shows progress but remains early stage. Current price near support at $67 suggests limited downside, while analyst targets indicate 4.6% upside potential. Key risks include litigation exposure and slower-than-expected diversification from traditional tobacco products.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Vanguard Mega Cap Growth ETF

MGK is an ETF that seeks to track the performance of the CRSP US Mega Cap Growth Index. It provides a low-cost, diversified exposure to the largest growth companies in the U.S. stock market. The fund is composed of mega-cap stocks that exhibit key growth factors, including high expected long-term earnings growth, high historical sales and earnings growth, and high return on assets. MGK is typically used by investors seeking long-term capital appreciation from market-leading firms.

Read more on MGK

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO